These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32793396)

  • 1. Emerging role of FBXO22 in carcinogenesis.
    Cheng J; Lin M; Chu M; Gong L; Bi Y; Zhao Y
    Cell Death Discov; 2020; 6():66. PubMed ID: 32793396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBXO22, an epigenetic multiplayer coordinating senescence, hormone signaling, and metastasis.
    Johmura Y; Harris AS; Ohta T; Nakanishi M
    Cancer Sci; 2020 Aug; 111(8):2718-2725. PubMed ID: 32536008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCF
    Bai J; Wu K; Cao MH; Yang Y; Pan Y; Liu H; He Y; Itahana Y; Huang L; Zheng JN; Pan ZQ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11754-11763. PubMed ID: 31138683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
    Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence.
    Johmura Y; Sun J; Kitagawa K; Nakanishi K; Kuno T; Naiki-Ito A; Sawada Y; Miyamoto T; Okabe A; Aburatani H; Li S; Miyoshi I; Takahashi S; Kitagawa M; Nakanishi M
    Nat Commun; 2016 Feb; 7():10574. PubMed ID: 26868148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression.
    Sun R; Xie HY; Qian JX; Huang YN; Yang F; Zhang FL; Shao ZM; Li DQ
    Cancer Res; 2018 Sep; 78(18):5274-5286. PubMed ID: 29945959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumorigenesis.
    Liu P; Cong X; Liao S; Jia X; Wang X; Dai W; Zhai L; Zhao L; Ji J; Ni D; Liu Z; Chen Y; Pan L; Liu W; Zhang J; Huang M; Liu B; Tan M
    Cell Death Differ; 2022 Jan; 29(1):1-13. PubMed ID: 34215846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-Cancer Analyses Reveal Oncogenic Role and Prognostic Value of F-Box Only Protein 22.
    Chen S; Ma S; Yan J; Wang H; Ding B; Guo Z; Ma Y; Chen X; Wang Y
    Front Oncol; 2021; 11():790912. PubMed ID: 35141150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F-Box Protein FBXO22 Mediates Polyubiquitination and Degradation of CD147 to Reverse Cisplatin Resistance of Tumor Cells.
    Wu B; Liu ZY; Cui J; Yang XM; Jing L; Zhou Y; Chen ZN; Jiang JL
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA SNHG14 promotes osteosarcoma progression via miR-433-3p/FBXO22 axis.
    Hou XK; Mao JS
    Biochem Biophys Res Commun; 2020 Mar; 523(3):766-772. PubMed ID: 31948764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression.
    Tian X; Dai S; Sun J; Jin G; Jiang S; Meng F; Li Y; Wu D; Jiang Y
    Oncotarget; 2015 Sep; 6(26):22767-75. PubMed ID: 26087183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fbxo22 inhibits metastasis in triple-negative breast cancer through ubiquitin modification of KDM5A and regulation of H3K4me3 demethylation.
    Li S; He J; Liao X; He Y; Chen R; Chen J; Hu S; Sun J
    Cell Biol Toxicol; 2023 Aug; 39(4):1641-1655. PubMed ID: 36112263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXO22 Promotes Growth and Metastasis and Inhibits Autophagy in Epithelial Ovarian Cancers
    Li M; Zhao X; Yong H; Shang B; Lou W; Wang Y; Bai J
    Front Pharmacol; 2021; 12():778698. PubMed ID: 34950036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCF(FBXO22) regulates histone H3 lysine 9 and 36 methylation levels by targeting histone demethylase KDM4A for ubiquitin-mediated proteasomal degradation.
    Tan MK; Lim HJ; Harper JW
    Mol Cell Biol; 2011 Sep; 31(18):3687-99. PubMed ID: 21768309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53/p53-FBXO22-TFEB controls basal autophagy to govern hormesis.
    Suzuki N; Johmura Y; Wang TW; Migita T; Wu W; Noguchi R; Yamaguchi K; Furukawa Y; Nakamura S; Miyoshi I; Yoshimori T; Ohta T; Nakanishi M
    Autophagy; 2021 Nov; 17(11):3776-3793. PubMed ID: 33706682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.
    Johmura Y; Maeda I; Suzuki N; Wu W; Goda A; Morita M; Yamaguchi K; Yamamoto M; Nagasawa S; Kojima Y; Tsugawa K; Inoue N; Miyoshi Y; Osako T; Akiyama F; Maruyama R; Inoue JI; Furukawa Y; Ohta T; Nakanishi M
    J Clin Invest; 2018 Dec; 128(12):5603-5619. PubMed ID: 30418174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1.
    Lignitto L; LeBoeuf SE; Homer H; Jiang S; Askenazi M; Karakousi TR; Pass HI; Bhutkar AJ; Tsirigos A; Ueberheide B; Sayin VI; Papagiannakopoulos T; Pagano M
    Cell; 2019 Jul; 178(2):316-329.e18. PubMed ID: 31257023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis.
    Guo F; Liu J; Han X; Zhang X; Lin T; Wang Y; Bai J; Han J
    Int J Biol Sci; 2019; 15(3):647-656. PubMed ID: 30745851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circ_0006282 Contributes to the Progression of Gastric Cancer by Sponging miR-155 to Upregulate the Expression of FBXO22.
    He Y; Wang Y; Liu L; Liu S; Liang L; Chen Y; Zhu Z
    Onco Targets Ther; 2020; 13():1001-1010. PubMed ID: 32099403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXO22 promotes glioblastoma malignant progression by mediating VHL ubiquitination and degradation.
    Shen Z; Dong T; Yong H; Deng C; Chen C; Chen X; Chen M; Chu S; Zheng J; Li Z; Bai J
    Cell Death Discov; 2024 Mar; 10(1):151. PubMed ID: 38519492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.